News Conference News EuroPCR 2016 LAA Closure May Provide Solution for Stroke Prevention in Patients With Prior Intracerebral Hemorrhage Yael L. Maxwell May 18, 2016
News Conference News EuroPCR 2016 EWOLUTION Confirms Safety, Efficacy for Real-World Use of Watchman, Even With No Postprocedural Drug Therapy Yael L. Maxwell May 17, 2016
News Daily News Adherence to Guideline-Based Acute MI Therapies Has Prolonged Impact on Mortality Rates Michael O'Riordan May 17, 2016
News Daily News La Adherencia a los Tratamientos de los IAM basados en las Directrices Tiene un Impacto Prolongado en las Tasas de Mortalidad Michael O'Riordan May 17, 2016
News Daily News Anticoagulation May Not Be Necessary When Replacing Aortic Valve With Bioprosthesis, Meta-analysis Suggests Todd Neale May 12, 2016
News Daily News Ticagrelor Doesn’t Beat Aspirin for Secondary Prevention After Stroke-TIA: SOCRATES Todd Neale May 11, 2016
News Daily News SOCRATES: Ticagrelor No Supera a la Aspirina en Prevención Secundaria Post ACV-AIT Todd Neale May 11, 2016
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for April 2016 Shelley Wood April 29, 2016
News Daily News Observational Study Supports Longer-Term Monitoring for A-fib After Cryptogenic Stroke Todd Neale April 22, 2016
News Daily News Good Warfarin Management Prevents Complications in A-fib Patients, Swedish Study Contends L.A. McKeown April 21, 2016
News Daily News USPSTF Tightens Up Primary-Prevention Recommendations, Saying Aspirin Should Be Used Only in High-Risk Individuals Michael O'Riordan April 12, 2016
News Daily News El USPSTF Refuerza las Recomendaciones en materia de Prevención Primaria al asegurar que la Aspirina Solo Debería de Emplearse en Sujetos de Riesgo Alto Michael O'Riordan April 12, 2016
News Conference News ACC 2016 Comparing the Novel Oral Anticoagulants: Effectiveness Similar, but Apixaban May Come With Less Bleeding Todd Neale April 06, 2016
News Conference News ACC 2016 More Evidence That Morphine Hampers Effects of Antiplatelet Therapy in STEMI Todd Neale April 02, 2016
News Daily News Updated US Guidelines Lower DAPT Duration From 12 to 6 Months in Stable Patients Receiving DES Yael L. Maxwell March 30, 2016
News Daily News Las Últimas Directrices Norteamericanas Reducen la Duración del Tratamiento Antiplaquetario Doble de 12 a 6 Meses en Pacientes Estables que Reciben un SLF Yael L. Maxwell March 30, 2016
News Industry News Aralez Announces FDA Acceptance of New Drug Application for YOSPRALA™ March 28, 2016
News Opinion Editor's Corner ACC 2016: HOPE for Primary Prevention, TAVR in Moderate-Risk Patients, Deferred Stenting in STEMI, and More Shelley Wood March 28, 2016